BioXXmed (ex: CytoTools) aus Darmstadt ist ein Biotech-Unternehmen, das Ergebnisse aus der Forschung zu Zellwachstum und programmiertem Zelltod in Therapieformen zur Krankheitsbehandlung und Heilung umsetzt.
COMPANY
INVESTOR TERMSHEET
T5O0

BioXXmed
#BGFL Mood: Negative · #BGFL-Indicator: Reduce · Review date: -
LEI: 8945005J8KVO36IW6P49
SECTOR: Gesundheit SUB-SECTOR: Biotechnologie
NAME
BioXXmed
WKN
A4BGGE
ISIN
DE000A4BGGE4
TICKER
T5O0
INDEX
EXCHANGE
Frankfurt
Made with ❤ von BGFL
The basic chart view shows the price movement of BioXXmed. If you are interested in additional analysis switch to the advanced chart view.
Even hardened fundamentalists probably look at the chart of a share before they start analysing it in any other way. Accordingly, boersengefluester.de (BGFL) has also developed a wide range of apps relating to chart technology and sophisticated scorings with technical chart components.

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
          Qualitätsjournalismus · Made in Germany © 2024          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2024 by Gereon Kruse #BGFL